Hercules Capital 

$24,94
4742
-$0,24-0,95% Dnes

Statistiky

Denní maximum
25,01
Denní minimum
24,94
52týdenní maximum
25,7
52týdenní minimum
24,71
Objem obchodů
4 036
Prům. objem
-
Tržní kap.
0
Poměr P/E
19,37
Dividendový výnos
6,2%
Dividenda
1,55

Nadcházející

Dividendy

6,2%Dividendový výnos
Apr 26
$0,39
Jan 26
$0,39
Oct 25
$0,39
Jul 25
$0,39
Apr 25
$0,39
10letý růst
N/A
5letý růst
-0%
3letý růst
-0%
Růst za 1 rok
-0,01%

Výsledky hospodaření

30JulOčekávané
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Další
0,45
0,47
0,49
0,5
Očekávané EPS
0.485313
Skutečný EPS
N/A

Finanční údaje

61,21%Zisková marže
Zisková
2017
2018
2019
2020
2021
2022
307,26MTržby
188,07MČistý zisk

Doporučení analytiků

18,13Průměrná cílová cena
Nejvyšší odhad je 22,00.
Na základě 4 hodnocení za posledních 6 měsíců. Nejde o investiční doporučení.
Koupit
25%
Držet
75%
Prodat
0%

Lidé také sledují

Tento seznam vychází ze seznamů sledovaných titulů uživatelů Stock Events, kteří sledují HCXY. Není to investiční doporučení.

Konkurenti

Tento seznam je analýza založená na nedávných tržních událostech. Nejde o investiční doporučení.

O aplikaci

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in North America and Europe.
Show more...
CEO
Zaměstnanci
100
Země
Spojené státy
ISIN
US4270968476

Zalistování

0 Comments

Poděl se o svůj názor

FAQ

Jaká je dnes cena akcie společnosti Hercules Capital?
Aktuální cena akcie HCXY je $24,94 USD — za posledních 24 hodin klesla o -0,95%. Vývoj ceny akcie společnosti Hercules Capital můžete podrobněji sledovat v grafu.
Jaký ticker má akcie společnosti Hercules Capital?
Ticker akcie se může lišit podle burzy. Například na burze se akcie společnosti Hercules Capital obchodují pod tickerem HCXY.
Roste cena akcií společnosti Hercules Capital?
Akcie HCXY oproti předchozímu týdnu klesly o -1,08%, za poslední měsíc vzrostly o +0,24% a za poslední rok akcie společnosti Hercules Capital posílily o +0,32%.
Kdy Hercules Capital zveřejní další výsledky?
Hercules Capital zveřejní další výsledky hospodaření dne července 30, 2026.
Jaké byly výsledky hospodaření společnosti Hercules Capital za minulé čtvrtletí?
Zisk na akcii u HCXY za poslední čtvrtletí byl 0,48 USD, zatímco odhad činil 0,48 USD, což představuje překvapení ve výši +0,55%. Odhadovaný zisk na akcii pro příští čtvrtletí je N/A USD.
Jaké byly tržby společnosti Hercules Capital za minulý rok?
Tržby společnosti Hercules Capital za poslední rok činí 307,26M USD.
Jaký je čistý zisk společnosti Hercules Capital za minulý rok?
Čistý zisk HCXY za poslední rok činí 188,07M USD.
Vyplácí Hercules Capital dividendy?
Ano, dividendy HCXY se vyplácejí čtvrtletně. Poslední dividenda na akcii činila 0,39 USD. K dnešnímu dni je dividendový výnos (FWD)% 6,2%.
Kolik má Hercules Capital zaměstnanců?
Ke dni června 11, 2026 má společnost 100 zaměstnanců.
Do jakého sektoru patří Hercules Capital?
Hercules Capital působí v sektoru Finance & Payments.
Kdy společnost Hercules Capital provedla split akcií?
Společnost Hercules Capital v poslední době neprovedla žádný split akcií.